24 February

Over 100 MEPs call for a TRIPS Waiver

10 February

Access to Medicines in Europe

24 November

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

6 October

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

30 September

What do the next five years have in store for the European Medicines Agency?

20 August

Dutch institutions failing to register results of clinical trials

28 April

EU Must Not Miss its Chance on WHO Technology Pool

24 April

TRIPS-flexibilities in Health Crises and Beyond

13 March

HAI Follows Dutch Government Advice in Response to COVID-19

21 February

What Role Can Civil Society Play in the European Regulatory Process?

7 February

Open Science for Health: Shaping the New Framework Programme

14 December

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

15 February

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

1 December

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

9 June

HAI urges MEPs to support key amendments to TTIP resolution

4 February

The EU-US Trade Deal Could Leave Europeans Sick

15 October

EMA policy on clinical data publication a step ahead, but falls short of true potential

18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

2 September

Report exposes how Big Pharma has hijacked EU-India trade deal

28 April

HAI hosts essay competition for students